Literature DB >> 15679728

CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children.

S La Grutta1, P Richiusa, G Pizzolanti, A Mattina, G B Pajno, R Citarrella, G Passalacqua, C Giordano.   

Abstract

BACKGROUND: In atopic dermatitis (AD) a Th1/Th2 imbalance has been reported, and interleukin (IL)-13 seems to play a pivotal role in the inflammatory network. We tried to assess the correlation between the immunological marker CD4(+)IL-13(+) and the clinical phase of extrinsic AD in children.
METHODS: Twenty children with AD were studied. Assessed parameters were: clinical severity (SCORAD index), total serum immunoglobulin E (IgE), blood eosinophil count, and percentage of CD4(+)IFNgamma(+), CD4(+)IL-4(+), CD4(+)IL-13(+) T cells. Determinations were carried out in the acute phase and after clinical remission were achieved. Ten nonatopic-matched children served as controls.
RESULTS: At baseline, AD was mild in 25%, moderate in 50% and severe in 25% of children. In the acute phase a significant relationship between the eosinophil count and the SCORAD index was found (P = 0.0001). Blood CD4(+)IL-4(+) were significantly higher in the AD group (median 17.0, range: 13.7-21.4) than in controls (12.6, 6.4-17.2, P < 0.0001). CD4(+)IL-13(+) cells in the AD group well correlated (P = 0.0007) with SCORAD index. At remission, a significant correlation between SCORAD index and eosinophil count was found (P < 0.03) and the percentage of CD4(+)IL-13(+) cells globally decreased (P < 0.0001), while no difference was found among SCORAD classes.
CONCLUSION: This study confirms the Th2 profile predominance in the peripheral blood of children with AD, and evidences close relationship between the number of CD4(+)IL-13(+) T cells and the disease's severity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15679728     DOI: 10.1111/j.1398-9995.2005.00733.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  17 in total

1.  IL-13Rα2 has a protective role in a mouse model of cutaneous inflammation.

Authors:  Umasundari Sivaprasad; Manoj R Warrier; Aaron M Gibson; Weiguo Chen; Yasuhiro Tabata; Stacey A Bass; Marc E Rothenberg; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

2.  Intracellular production of IL-2, IL-4, IFN-gamma, and TNF-alpha by peripheral blood CD3+ and CD4+ T cells in children with atopic dermatitis.

Authors:  Edyta Machura; Bogdan Mazur; Jarosław Kwiecień; Krystyna Karczewska
Journal:  Eur J Pediatr       Date:  2006-11-21       Impact factor: 3.183

3.  Th2 Cytokines and Atopic Dermatitis.

Authors:  Eric B Brandt; Umasundari Sivaprasad
Journal:  J Clin Cell Immunol       Date:  2011-08-10

4.  Impact of T-cell receptor Vbeta haplotypes on the development of dermatitis in DS-Nh mice: synergistic production of interleukin-13 caused by staphylococcal enterotoxin C and peptide glycans from Staphylococcus aureus.

Authors:  Takeshi Yoshioka; Kinichi Imura; Ichiro Hikita; Tsutomu Hirasawa; Tsuneaki Sakata; Takaji Matsutani; Tatsuya Horikawa; Akinori Arimura
Journal:  Immunology       Date:  2007-02-20       Impact factor: 7.397

Review 5.  The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.

Authors:  Patrick M Brunner; Emma Guttman-Yassky; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2017-04       Impact factor: 10.793

6.  In vitro assessment of IL-4- or IL-13-mediated changes in the structural components of keratinocytes in mice and humans.

Authors:  Miyuki Omori-Miyake; Masakatsu Yamashita; Yuichiro Tsunemi; Makoto Kawashima; Junji Yagi
Journal:  J Invest Dermatol       Date:  2013-11-26       Impact factor: 8.551

Review 7.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Sarah L Chamlin; Steven R Feldman; Jon M Hanifin; Eric L Simpson; Timothy G Berger; James N Bergman; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Robert A Silverman; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2013-11-27       Impact factor: 11.527

8.  Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets.

Authors:  Tali Czarnowicki; Hitokazu Esaki; Juana Gonzalez; Dana Malajian; Avner Shemer; Shinji Noda; Sreya Talasila; Adam Berry; Jayla Gray; Lauren Becker; Yeriel Estrada; Hui Xu; Xiuzhong Zheng; Mayte Suárez-Fariñas; James G Krueger; Amy S Paller; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2015-08-01       Impact factor: 10.793

9.  IL13 genetic polymorphisms, smoking, and eczema in women: a case-control study in Japan.

Authors:  Yoshihiro Miyake; Keiko Tanaka; Masashi Arakawa
Journal:  BMC Med Genet       Date:  2011-10-21       Impact factor: 2.103

10.  Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production.

Authors:  Maryam Salimi; Luzheng Xue; Helen Jolin; Clare Hardman; David J Cousins; Andrew N J McKenzie; Graham S Ogg
Journal:  J Immunol       Date:  2015-11-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.